Sector Update: Healthcare

By
A A A

Healthcare shares are lower in pre-market, while NPS Pharmaceuticals ( NPSP ) is up about 4% in pre-market trade as it said the U.S. Food and Drug Administration has accepted for review its supplemental new drug application for Gattex for injection to treat short bowel syndrome in adults who are dependent on parenteral support.

And, shares of Sinovac Biotech Ltd. ( SVA ) are up nearly 10% at $6.45 in pre-market after the China-based biopharmaceutical company reported overnight a net income in Q3 2013 on increased sales, driven by the expanded capacity of SVA's fully operational Changping filling and packaging line.

SVA said net income was $2.3 million, or $0.04 per diluted share, compared to a net loss of $3 million, or $0.05 per diluted share, in the same period last year. Sales totaled $22.1 million, up 54.5% from $14.3 million in the prior-year quarter.

No analyst estimates were available for comparison.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: NPSP , SVA

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

THE COST OF HOUSE FLIPPING
THE COST OF HOUSE FLIPPING          

Stocks

Referenced

Most Active by Volume

83,946,369
  • $16.40 ▼ 1.20%
65,919,147
  • $102.99 ▲ 0.51%
63,004,409
  • $42 ▲ 4.53%
42,618,740
  • $7.93 ▼ 2.94%
41,388,613
  • $78.37 ▼ 0.41%
40,438,996
  • $3.81 ▲ 14.76%
39,835,674
  • $12.32 ▲ 2.41%
38,147,728
  • $12.83 ▼ 2.80%
As of 10/22/2014, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com